Zobrazeno 11 - 20
of 194
pro vyhledávání: '"Matteo Pirro"'
Autor:
Gerald F. Watts, Stephen L. Atkin, Khalid Al-Rasadi, Luis E. Simental-Mendía, Cesare Sirtori, Matteo Pirro, Amirhossein Sahebkar, Maciej Banach
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Autor:
Vanessa Bianconi, Franco Baldelli, Chiara Busti, Salvatore Cardaci, Mannarino, Daniela Francisci, Elisabetta Schiaroli, Matteo Pirro
OBJECTIVES Plasma levels of proprotein convertase subtilisin/kexin type 9 (PCSK9), a major regulator of cholesterol metabolism, have been reported to have an increasing trend in people living with HIV (PLWH) compared with controls. We assessed the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ed0b7b82b2f02fe9dd6e8aa606a06b9
http://hdl.handle.net/11391/1472220
http://hdl.handle.net/11391/1472220
Autor:
Roberto Volpe, Matteo Pirro, Bruno Trimarco, Alessandro Biffi, Simonetta Bellone, Agostino Consoli, Giulio Nati, Giuliano Tocci, Claudio Ferri, Paolo Bellotti, Marco Bertolotti, Saula Vigili de Kreutzenberg, Massimo Volpe, Allegra Battistoni, Maria Grazia Modena, Speranza Rubattu, Alberto Corsini, Giovambattista Desideri
Publikováno v:
High Blood Pressure & Cardiovascular Prevention
In 2020, the Sars-Cov-2 pandemic is causing a huge and dramatic impact on healthcare systems worldwide. During this emergency, fragile patients suffering from other comorbidities, especially patients susceptible to or affected by cardiovascular disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d24ad761318b88c41884224182d2d0d
http://hdl.handle.net/11577/3451660
http://hdl.handle.net/11577/3451660
Autor:
Niki Katsiki, Dimitri P. Mikhailidis, Gani Bajraktari, Andre R. Miserez, Arrigo F.G. Cicero, Eric Bruckert, Maria-Corina Serban, Erkin Mirrakhimov, Fahad Alnouri, Željko Reiner, György Paragh, Amirhossein Sahebkar, Maciej Banach, Fahma Amar, Atanas G. Atanasov, Marcin A. Bartlomiejczyk, Bojko Bjelakovic, Agata Bielecka-Dabrowa, Alberto Cafferata, Richard Ceska, Xavier Collet, Olivier Descamps, Nair Devaki, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Stephan von Haehling, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Olena Mitchenko, Patrick Moriarty, Seyed Mohammad Nabavi, Demosthenes B. Panagiotakos, Daniel Pella, Peter E. Penson, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Naveed Sattar, Abdulla M.A. Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Toth, Margus Viigimaa, Dragos Vinereanu, Branislav Vohnout, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng, Andreas Zirlik
Acute and chronic physical exercises may enhance the development of statin-related myopathy. In this context, the recent (2019) guidelines of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) for the management o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64aad141de12106170606d1ea9c55180
http://hdl.handle.net/11585/757681
http://hdl.handle.net/11585/757681
Autor:
Angela Pirillo, Bernhard Föger, Alberico L. Catapano, Catriona Jennings, Matteo Pirro, Lale Tokgozoglu
The availability of efficient lipid-lowering drugs has substantially reduced the incidence and mortality for cardiovascular disease (CVD). Despite that, CVD still represents a major cause of death and disability; efforts are thus required to prevent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6943aa0e909391eed68a34113c061290
http://hdl.handle.net/11391/1526429
http://hdl.handle.net/11391/1526429
Autor:
Yunes Panahi, Matteo Pirro, Vanessa Bianconi, Maryam Moshkani Farahani, Amirhossein Sahebkar, Maciej Banach, M A Safarpour, M S Jamshir, Mohsen Sadeghi Ghahrodi
Publikováno v:
European Heart Journal. 40
Background Plasma PCSK9 levels, a novel and effective therapeutic target for CVD prevention, have been associated with CVD events irrespective of traditional risk factors. Whether PCSK9 levels predict coronary artery disease (CAD) burden and severity
Publikováno v:
Drug Discovery Today. 22:883-895
Diabetes mellitus (DM) is associated with an increased risk of cardiovascular disease (CVD). Inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9) have emerged as effective low-density lipoprotein cholesterol-lowering compounds. Althoug
Publikováno v:
Clinical Reviews in Allergy & Immunology
Familial hypercholesterolemia (FH) is the most common inherited form of dyslipidemia and a major cause of premature cardiovascular disease. Management of FH mainly relies on the efficiency of treatments that reduce plasma low-density lipoprotein (LDL
Autor:
Gerald F. Watts, Dimitri P. Mikhailidis, Matteo Pirro, Maciej Banach, Amirhossein Sahebkar, Arrigo F G Cicero
Publikováno v:
Drugs. 78(1)
Uric acid (UA), the final product of purine catabolism, may be associated with an increased risk of cardiovascular disease. The aim of this meta-analysis of randomized placebo-controlled trials was to evaluate whether lowering serum UA (SUA) levels w
Autor:
Anders Hamsten, Elena Tremoli, Ewa Ehrenborg, V. Janas, A. Franco-Cereceda, Matteo Pirro, Damiano Baldassarre, Marju Orho-Melander, Karl Gertow, S. Pourteymour, Peter Eriksson, Paolo Parini, Fabrizio Veglia, Peter Saliba-Gustafsson, Matteo Pedrelli, Andries J. Smit, Sudhir Kurl, Joëlle Magné, Rainer Rauramaa, Isabel Gonçalves, Jan Borén, U de Faire, S.E. Humphries, P. Giral, O. Werngren
Publikováno v:
Journal of Internal Medicine. Wiley
J Intern Med
Journal of Internal Medicine
J Intern Med
Journal of Internal Medicine
Background Hyperlipidaemia is a major risk factor for cardiovascular disease, and atherosclerosis is the underlying cause of both myocardial infarction and stroke. We have previously shown that the Pro251 variant of perilipin‐2 reduces plasma trigl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ed957d547fbab1ba2005518beb52825
https://research.rug.nl/en/publications/2668fdf7-9d32-421c-bffc-68a95c7151ee
https://research.rug.nl/en/publications/2668fdf7-9d32-421c-bffc-68a95c7151ee